Treatment of Lupus Nephritis with anti-CD20 Followed by Anti-BAFF: Impact on B Cell Reconstitution, B Cell Subsets, and Autoreactivity

被引：0
|
作者：
Fregoso, Yemil Atisha [1 ]
Malkiel, Susan [1 ]
Harris, Kristina [2 ]
Kanaparthi, Sai [2 ]
Byron, Margie [3 ]
Ding, Linna [4 ]
Smilek, Dawn [5 ]
Wofsy, David [6 ]
Dall'Era, Maria [7 ]
Aranow, Cynthia [1 ]
Diamond, Betty [1 ]
机构：
[1] Feinstein Inst Med Res, Manhasset, NY USA
[2] Immune Tolerance Network, Bethesda, MD USA
[3] Rho Fed Syst Inc, Chapel Hill, NC USA
[4] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA
[5] Immune Tolerance Network, San Francisco, CA USA
[6] UCSF, San Francisco, CA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0941
引用
收藏
页数：4
相关论文
共 50 条
  • [41] B Cell Targeting Therapy Using the Anti-CD20 Antibody in Autoimmune Diseases
    Tanaka, Yoshiya
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (06): : 675 - 679
  • [42] Monocytes mediate shaving of B-cell-bound anti-CD20 antibodies
    Pedersen, Anders E.
    Jungersen, Mette B.
    Pedersen, Charlotte D.
    IMMUNOLOGY, 2011, 133 (02) : 239 - 245
  • [43] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2001, 15 : 1667 - 1667
  • [44] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    LEUKEMIA, 2001, 15 (10) : 1667 - 1667
  • [45] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    R. O. Dillman
    Clinical and Experimental Medicine, 2006, 6
  • [46] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    Dillman, RO
    CLINICAL AND EXPERIMENTAL MEDICINE, 2006, 6 (01) : 1 - 12
  • [47] Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
    Fagnano, Ester
    Pendharkar, Swati
    Colton, Madyson
    Jones, Philip N.
    Sallan, Marta Crespi
    Klymenko, Tetyana
    Braun, Andrejs
    Klein, Christian
    Honeychurch, Jamie
    Cheadle, Eleanor J.
    Illidge, Timothy M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [48] ABNORMAL MEMORY B-CELL RECONSTITUTION FOLLOWING ANTI-CD20 THERAPY FOR AUTOIMMUNE DISEASES PREDICTS CLINICAL RELAPSE
    Arumugakani, G.
    Rawstron, A.
    Tooze, R.
    Cherukuri, A.
    Varghese, A.
    Vital, E.
    Emery, P.
    McGonagle, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 183 - 183
  • [49] An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus
    RA Eisenberg
    S Khan
    J Stansberry
    D Tsai
    S Kolasinski
    E Rieder
    B Kotzin
    RJ Looney
    C Strieber
    D Albert
    Arthritis Res Ther, 6 (Suppl 3):
  • [50] Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-Cell malignancies
    Bornstein, Gadi Gazit
    Queva, Christophe
    Tabrizi, Mohammad
    VanAbbema, Anne
    Chavez, Carlos
    Wang, Ping
    Laing, Naomi
    Raja, Sandhya
    Wen, Shenghua
    Rong, Xianhui
    Green, Larry L.
    Yang, Xiaodong
    Blakey, David
    BLOOD, 2007, 110 (11) : 694A - 695A
12345